Posttreatment imaging characterization of the studied sample comparing patients with and without CLL
| Total (n = 139) | Patients with CLL (n = 23) | Patients without CLL (n = 116) | P Valuea | |
|---|---|---|---|---|
| LE, No. (%) | <.001 | |||
| No | 81 | 4 (4.9) | 77 (95.1) | |
| Yes | 58 | 19 (32.8) | 39 (67.2) | |
| Fazekas scale, No. (%) | .001 | |||
| Grade 0 | 81 | 4 (4.9) | 77 (95.1) | |
| Grade 1 | 32 | 4 (12.5) | 28 (87.5) | |
| Grade 2 | 13 | 7 (53.8) | 6 (46.2) | |
| Grade 3 | 13 | 8 (61.5) | 5 (38.5) | |
| Microbleeds, No. (%) | .248 | |||
| Yes | 88 | 17 (19.3) | 71 (80.7) | |
| No | 51 | 6 (11.8) | 45 (88.2) | |
| Cavernomas, No. (%) | .129 | |||
| Yes | 53 | 12 (22.6) | 41 (77.4) | |
| No | 86 | 11 (12.8) | 75 (87.2) |
↵a P values were obtained by the χ2 test.